| Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma | JCI insight |  | | 2025 | 8 | 31 |
|
| Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC : From Bedside to Bench and Back | BioDrugs | | | 2025 | 61 | 1,050 |
|
| Case Report : Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring NF1 mutation : a case series and literature review | Frontiers in oncology | | | 2025 | 10 | 408 |
|
| Unveiling the landscape of uncommon EGFR mutations in NSCLC-A systematic review | Journal of thoracic oncology | | | 2024 | 180 | 1,296 |
|
| Management of stage III non-small-cell lung cancer : rays of hope | Exploration of targeted anti-tumor therapy | | | 2024 | 81 | 265 |
|
| Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in NSCLC : A Brief Report | Journal of thoracic oncology | | | 2024 | 53 | 168 |
|
| Rates of febrile neutropenia and its causes in the real world | Future oncology | | | 2024 | 39 | 523 |
|
| Bringing immune-checkpoint inhibitors earlier in the management of non-small cell lung cancer | Translational lung cancer research | | | 2023 | 110 | 78 |
|
| The evolving role of immune-checkpoint inhibitors in malignant pleural mesothelioma | Journal of clinical medicine | | | 2023 | 58 | 174 |
|
| Novel targets for immune-checkpoint inhibition in cancer | Cancer treatment reviews | | | 2023 | 113 | 142 |
|
